【hacked my singing monsters apk】Sanofi to Withdraw Zantac After FDA Warns of Carcinogens
Sanofi
SNY will have to withdraw its heartburn drug,hacked my singing monsters apk Zantac, from U.S. markets, following FDA’s request.
The FDA has requested drugmakers marketing ranitidine, which is widely available by the brand name of Zantac, to immediately withdraw all prescription and OTC versions from the market. The FDA in its investigations observed that the ranitidine medications, which are approved for treating heartburn associated with acid indigestion, contain a carcinogenic contaminant, N-Nitrosodimethylamine ("NDMA").
Please note that in October 2019 Sanofi initiated a voluntary recall of all Zantac over-the-counter (“OTC”) versions — Zantac 150, Zantac 150 Cool Mint, and Zantac 75 — in the United States. The decision was made by the company as a precautionary measure following a public statement from the FDA in September, alerting about a possible contamination of ranitidine medications.
Due to recall of Zantac, Sanofi reported that sales of its Consumer Healthcare GBU declined 12.8% in the United States in the fourth quarter 2019. Complete withdrawal of the drug will further impact sales unfavorably in 2020. A few other generic drugmakers marketing ranitidine medications had also initiated voluntary recall of the drugs last year, including Perrigo PRGO and Lannett Company LCI.
Shares of Sanofi have lost 14.6% so far this year compared with the industry’s decrease of 11.1%.
Although low-levels of NDMA do not increase risk of cancer, the FDA has determined that NDMA in some ranitidine products increases with time and when medications are stored at higher than room temperatures. These can lead to consumer exposure to unacceptable levels of NDMA, which the agency states may cause cancer.
However, director of the FDA’s Center for Drug Evaluation and Research stated that though the agency had not observed unacceptable levels of NDMA in many of the samples that were tested, it was unsure of storage duration and conditions of the samples. Hence, as a precaution, the FDA decided that ranitidine medications should not be available to consumers and patients unless its quality can be assured.
With this withdrawal request, ranitidine medications will not be available for new or existing prescriptions or OTC use in the United States. The FDA has suggested alternative drugs for use, including famotidine (Pepcid), cimetidine (Tagamet), esomeprazole (AstraZeneca’s AZN Nexium), lansoprazole (Takeda Pharmaceuticals’ Prevacid) or omeprazole (Prilosec). These medications are not found to contain NDMA.
Story continues
Sanofi Price
Sanofi Price
Sanofi price | Sanofi Quote
Zacks Rank
Sanofi currently carries a Zacks Rank #3 (Hold). You can see
the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
Sanofi (SNY) : Free Stock Analysis Report
AstraZeneca PLC (AZN) : Free Stock Analysis Report
Perrigo Company plc (PRGO) : Free Stock Analysis Report
Lannett Co Inc (LCI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
View comments
下一篇:Coronavirus spread in Canada is slowing - Public Health Agency
相关文章:
- Backend Benchmarking Publishes 17th Edition of The Robo Report Covering the 3rd Quarter of 2020
- Fortnite Store Accepts Crypto – But Only Monero
- Japan final Feb manufacturing PMI confirms fastest pace of decline in two-and-a-half years
- Should You Be Worried About Insider Transactions At Canopy Growth Corporation (TSE:WEED)?
- Labrador Iron Ore Royalty Corporation Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
- BRIEF-Qingdao Hanhe Cable Says It Wins State Grid's Bids For A Combined 470 Million Yuan
- January jobs report — What to know in markets Friday
- Are You the Right Investor for U.S. Oil and Gas Royalty Trusts? In Depth Analysis of Expectations for Future Cash Flows Before an Investment Decision Is Required
- No matter how long you've been at this, your small business is now a startup
- Is Alstom SA's (EPA:ALO) Capital Allocation Ability Worth Your Time?
相关推荐:
- Coronavirus to have substantial impact on trade: WTO
- Manhattan real estate prices hit record
- SoftBank Robotics Removes Strategy Executive Steve Carlin
- Gap Inc (GPS) Q4 2018 Earnings Conference Call Transcript
- Asian Shares Lower as US-China Tensions Weigh on Investor Sentiment
- Why We’re Not Impressed By Fullshare Holdings Limited’s (HKG:607) 0.6% ROCE
- Robert Carlyle hints at Trainspotting 2 details
- Does The Madras Fertilizers Limited (NSE:MADRASFERT) Share Price Tend To Follow The Market?
- What Does BNP Paribas Know That the Markets Don't?
- How to Watch the 2019 Golden Globes on Sunday
- MT Højgaard Holding A/S: Financial Calendar 2021
- Cheap oil prices likely to reduce inflationary pressures in India: government adviser
- SHAREHOLDER ALERT: TUFN EHTH R: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
- Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
- How Are PlayStation 5, Xbox Poised Before Launch?
- Role of Wireless ICT in Healthcare Markets, 2020 Report - Focus on WICT and M2M Communications, Self-powered Wireless Sensors, Underlying Technologies, & WBAN/WMBAN Features and Standardization
- Air Filters Case Study: Camfil Filters Provide Significant Energy Savings for a Leading American Frozen Food Manufacturer
- U.S. SEC eases crowdfunding rules for firms due to coronavirus disruption
- Glencore commits to net zero emissions by 2050
- Microsoft (MSFT) Is a Bargain Stock You Can Buy Today